What to Expect in Months 4-6 Minimal side effects: 85%+ patients report little to no symptoms Fastest weight loss period: Average loss 15-18% by week 24 Appetite suppression as primary effect: Not unpleasant, just not hungry Metabolic improvements: Blood pressure drops, triglycerides down 28%, A1C down 1.8% in diabetics Increased confidence and motivation: Visible results, compliments from others, clothes fitting differently Data from Diabetes Care journal shows this acceleration phase is when cardiovascular benefits become measurable, blood pressure improvements, lipid improvements, reduced inflammation markers
Benefits include: Better diabetes control Lower HbA1c Reduced insulin resistance 4
But don't your joints feel just frozen at that point
Accessed: 2024-10-14
Klinic handles this process for you by submitting the necessary clinical documentation to your insurer
After review of additional data, the 2023 ACC/AHA Guidelines for the Management of Patients with Chronic Coronary Disease published a strong (Class 1, LoE A) recommendation for the use of GLP-1 RA with proven cardiovascular benefits in patients with diabetes and chronic coronary disease to reduce the risk of MACE